KRAS and lung cancer: To investigate whether ACSL3 knockdown impairs PGE2 production in lung cancer cells carrying wild-type KRAS, we assessed four representative cancer cell lines with known differential sensitivity to ACSL3 knockdown, namely H596, H838, H125, and HCC95 (ref. [17] and Supplementary Table 1).